What screening is for, and what it cannot do

Screening tests people who feel well.

That single fact changes the entire calculation, and it is the part most often missed.

Screening versus diagnosis

• Diagnostic tests investigate a symptom.
• Screening tests look for disease before symptoms appear.
• The person being screened has nothing wrong that they know of.
• So any harm caused is inflicted on a well person.
• The threshold for benefit therefore has to be higher.

What a good screening programme requires

• The condition must be important and reasonably common.
• There must be a detectable earlier stage.
• Treating earlier must produce better outcomes.
• The test must be acceptable and reasonably accurate.
• There must be capacity to investigate and treat what is found.
• Missing any of these makes screening harmful rather than helpful.

False positives

• The test suggests something when nothing is wrong.
• This leads to further tests, sometimes invasive ones.
• It causes real anxiety, often lasting.
• It is common in any large screening programme.
• Ask how often it happens for the test you are offered.

False negatives

• The test misses something that is present.
• No screening test finds everything.
• A normal result is not a guarantee.
• New symptoms still need assessment regardless of recent screening.
• This is the most dangerous misunderstanding of screening.

Overdiagnosis

• Some things found by screening would never have caused harm.
• They still meet the definition of disease.
• They are therefore treated.
• That person receives all the harm of treatment and none of the benefit.
• This is not an error; it is inherent in early detection.

Why it is hard to see

• Nobody can tell which individual was overdiagnosed.
• Everyone treated feels that screening saved them.
• Overdiagnosis is visible only in population statistics.
• Personal stories therefore cannot settle the question.
• This is why programmes rely on trial evidence instead.

Why age and risk thresholds exist

• The chance of finding real disease rises with risk.
• Below a certain risk, harms outweigh benefits.
• Thresholds are set from trial evidence, not arbitrarily.
• They differ between countries because the evidence is weighed differently.
• Being outside the range is not a denial of care.

Questions to ask before any screening test

• What exactly does this look for?
• How often does it give a false alarm?
• What happens next if something is found?
• Would that next step be invasive?
• What would I do differently with a normal result?
• Is there evidence it reduces death or serious illness?

Private whole-body screening

• Marketed as thoroughness.
• Generates a high rate of incidental findings.
• Most of those findings are harmless.
• Investigating them has cost, risk and anxiety.
• Ask who manages the follow-up and who pays for it.
• Rarely recommended in the absence of specific risk.

Direct-to-consumer test panels

• Large panels of blood tests are sold directly to the public.
• Any large panel produces some abnormal results by chance.
• Reference ranges are defined so that some healthy people fall outside them.
• Ask who interprets the results.
• Ask who arranges follow-up for anything abnormal.

If you are at higher risk

• Family history may change what is recommended.
• Some conditions warrant earlier or more frequent screening.
• Tell your clinician your family history in detail.
• Ask whether specialist surveillance applies to you.
• Higher risk changes the balance genuinely.

Who runs the programme matters

• Organised national programmes track invitations, results and follow-up.
• Opportunistic testing does none of that reliably.
• Ask whether what you are offered is part of an organised programme.
• Ask who chases an abnormal result if you do not respond.
• A test with no safety net behind it is a weaker offer.

Declining screening is a legitimate choice

• Programmes are offers, not obligations.
• An informed decline is acceptable.
• Ask for the information in writing.
• You can change your mind later.
• Ask what symptoms would mean seeking help regardless.

Attending when you are invited

• Programmes work through repeated rounds, not single tests.
• Skipping rounds reduces the benefit substantially.
• Keep your contact details current with the programme.
• Rebook rather than ignoring a missed invitation.

Screening in different countries

• Ages, intervals and included conditions differ.
• Moving country may change what you are offered.
• Register with local services and ask what applies.
• Bring records of previous screening results.
• Do not assume you will be invited automatically.

The interval between rounds

• Intervals are chosen from how fast the condition develops.
• Shorter intervals do not automatically mean better protection.
• They do mean more tests, more false alarms and more cost.
• Ask why the interval is what it is.
• Ask what would justify a shorter one in your case.

Screening while you have symptoms

• Screening is for people without symptoms.
• If you have a symptom, say so rather than waiting for the next round.
• A symptom needs diagnostic assessment, which is a different pathway.
• Waiting for a scheduled screening invitation is a common and costly delay.
• Mention the symptom explicitly when you book.

What to do with an abnormal result

• Most abnormal screening results turn out to be nothing serious.
• Ask what the next step is and when.
• Ask how long results will take.
• Ask who to contact meanwhile.
• Do not search for worst cases while waiting.

The point to remember

Three things:

1. A normal result is not a guarantee — new symptoms still need assessment.
2. Ask what happens next if something is found, before agreeing to the test.
3. More screening is not automatically better — thresholds exist for reasons.

Câu hỏi thường gặp